Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)
Clinical trial NCT04436133 · COMPLETED
Trial details
- NCT number
- NCT04436133
- Sponsor
- National Vaccine and Serum Institute, China
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-20
- Primary completion
- 2022-03-01
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.